DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
HYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
HYDROCHLOROTHIAZIDE; LABETALOL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BUTALBITAL; ACETAMINOPHEN; CAFFEINE; CODEINE PHOSPHATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
BUTALBITAL; ACETAMINOPHEN; CAFFEINE; CODEINE PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE
4
Combination
Approved
Unknown
Unknown
Unknown
Unknown
EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACLIDINIUM BROMIDE; FORMOTEROL FUMARATE
4
Combination
Approved
Unknown
INHALATION
Unknown
Unknown
ACLIDINIUM BROMIDE; FORMOTEROL FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IODIPAMIDE MEGLUMINE
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
IODIPAMIDE MEGLUMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
X064O0Y1A4
Molecule Type:
Small molecule
Molecular Formula:
C34H48I6N4O16
Molecular Weight:
1530.19
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
FLURANDRENOLIDE; NEOMYCIN SULFATE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
FLURANDRENOLIDE; NEOMYCIN SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACETAMINOPHEN; PENTAZOCINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ACETAMINOPHEN; PENTAZOCINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
KRX-0502
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
KRX-0502
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DAPOXETINE
4
Small molecule
Approved
Unknown
Unknown
Erectile Dysfunction; Sexual Dysfunction, Physiological
Serotonin transporter inhibitor
DAPOXETINE
×
Maximum Phase:
4
First Approval:
None
UNII:
GB2433A4M3
Molecule Type:
Small molecule
Molecular Formula:
C21H23NO
Molecular Weight:
305.42
AlogP:
4.91
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
6.0
Source:
IMLIFIDASE
4
Enzyme
Unknown
Unknown
Unknown
Anti-Glomerular Basement Membrane Disease; Graft vs Host Disease; Purpura, Thrombocytopenic, Idiopathic; Renal Insufficiency, Chronic; Immune System Diseases
Antibodies hydrolytic enzyme
IMLIFIDASE
×
Maximum Phase:
4
First Approval:
None
UNII:
UVJ7NL8S2P
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K
4
Combination
Approved
OTHER
INTRAVENOUS
Unknown
Unknown
ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PODOPHYLLUM RESIN
4
Unknown
Approved
Unknown
Unknown
Condylomata Acuminata
Unknown
PODOPHYLLUM RESIN
×
Maximum Phase:
4
First Approval:
None
UNII:
16902YVY2B
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NORETHINDRONE; ETHINYL ESTRADIOL
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
NORETHINDRONE; ETHINYL ESTRADIOL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COLISTIN SULFATE; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; THONZONIUM BROMIDE
4
Combination
Approved
OTHER
OTIC
Unknown
Unknown
COLISTIN SULFATE; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; THONZONIUM BROMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDRALAZINE HYDROCHLORIDE; RESERPINE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
HYDRALAZINE HYDROCHLORIDE; RESERPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DROPERIDOL; FENTANYL CITRATE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
DROPERIDOL; FENTANYL CITRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TECHNETIUM TC-99M OXIDRONATE KIT
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
TECHNETIUM TC-99M OXIDRONATE KIT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INSULIN GLARGINE RECOMBINANT
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
INSULIN GLARGINE RECOMBINANT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LANADELUMAB (SHP643)
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
LANADELUMAB (SHP643)
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETHINYL ESTRADIOL; NORGESTREL
4
Combination
Approved
OTHER
ORAL-21; ORAL-28
Unknown
Unknown
ETHINYL ESTRADIOL; NORGESTREL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRIPARANOL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Delta(24)-sterol reductase inhibitor
TRIPARANOL
×
Maximum Phase:
4
First Approval:
None
UNII:
63S8C3RXGS
Molecule Type:
Small molecule
Molecular Formula:
C27H32ClNO2
Molecular Weight:
438.01
AlogP:
5.85
PSA:
32.7
HBD:
1.0
HBA:
#RotB:
10.0
Source:
MUZOLIMINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
MUZOLIMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
07Z36289ZX
Molecule Type:
Small molecule
Molecular Formula:
C11H11Cl2N3O
Molecular Weight:
272.13
AlogP:
2.56
PSA:
58.69
HBD:
1.0
HBA:
#RotB:
2.0
Source:
CLOMACRAN
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CLOMACRAN
×
Maximum Phase:
4
First Approval:
None
UNII:
5B1UZF65WW
Molecule Type:
Small molecule
Molecular Formula:
C18H21ClN2
Molecular Weight:
300.83
AlogP:
4.87
PSA:
15.27
HBD:
1.0
HBA:
#RotB:
4.0
Source:
GALLIUM CITRATE GA-67
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
GALLIUM CITRATE GA-67
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IODOHIPPURATE SODIUM I-123
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
IODOHIPPURATE SODIUM I-123
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIBISMUTH TRIOXIDE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
DIBISMUTH TRIOXIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BENZYDAMINE
4
Small molecule
Approved
Unknown
Unknown
Stomatitis; Arthralgia; Myalgia; Rheumatic Diseases; Vaginitis
Cyclooxygenase inhibitor
BENZYDAMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
4O21U048EF
Molecule Type:
Small molecule
Molecular Formula:
C19H23N3O
Molecular Weight:
309.41
AlogP:
3.42
PSA:
30.29
HBD:
0.0
HBA:
#RotB:
7.0
Source:
FLUOROMETHOLONE ACETATE; TOBRAMYCIN
4
Combination
Approved
OTHER
OPHTHALMIC
Unknown
Unknown
FLUOROMETHOLONE ACETATE; TOBRAMYCIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETHINYL ESTRADIOL; LEVONORGESTREL; FERROUS FUMARATE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
ETHINYL ESTRADIOL; LEVONORGESTREL; FERROUS FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BENFOTIAMINE
4
Small molecule
Approved
Unknown
Unknown
Diabetes Mellitus, Type 1; Alzheimer Disease; Diabetes Mellitus, Type 2; Diabetic Neuropathies
Unknown
BENFOTIAMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Y92OUS2H9B
Molecule Type:
Small molecule
Molecular Formula:
C19H23N4O6PS
Molecular Weight:
466.46
AlogP:
2.63
PSA:
155.94
HBD:
3.0
HBA:
#RotB:
10.0
Source:
TECHNETIUM TC-99M TILMANOCEPT
4
Protein
Approved
OTHER
INJECTION
Unknown
Unknown
TECHNETIUM TC-99M TILMANOCEPT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
4
Combination
Approved
OTHER
INTRAPERITONEAL
Unknown
Unknown
CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
269
270
271
272
273
274
275
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA